ISSN: 1745-7580
+44-77-2385-9429
Kasper Lamberth
Laboratory of Experimental Immunology,
Faculty of Health Sciences,
University of Copenhagen,
Copenhagen, Denmark
Kasper Lamberth, Ph.D., has very recently transitioned to the role as Department Head for Immunogenicity Prediction and Tolerance at Biopharmaceutical Research Unit, Novo Nordisk A/S. Dr. Lamberth joined Novo Nordisk 5 years ago and during this time he has worked with development of immunogenicity prediction tools as well as high throughput screening technologies. Prior to Novo Nordisk A/S, Dr. Lamberth worked for eight years with predictive immunogenicity tools, especially with MHC polymorphism and the identification of T-cell epitopes within the field of infectious diseases at Copenhagen University. Dr. Lamberth holds a MS in Biochemistry and a PhD in Immunology, both from Copenhagen University.
Chemical Biology of Molecules,Class II MHC molecule